Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...
In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...
Scientists say research into a vaccine for HIV is further along than it’s ever been.But Trump administration cuts to ...
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
A cutting edge pan-African HIV vaccine trial lost funding last year when the Trump administration shut down much of foreign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback